Regarding the TSP50 expression in CRC malignant cells and its relation to clinicopathological and prognostic factors, TSP50 overexpression in epithelial cells was observed more abundantly in moderately differentiated CRC than poorly differentiated tumors with no significant association between high TSP50 expression and tumor grade. The gene discussed is PRSS50; the disease is neoplasm.